186 related articles for article (PubMed ID: 31848813)
1. Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy.
Wang C; Yang J; Lu M
Ann Surg Oncol; 2020 Jun; 27(6):2051-2060. PubMed ID: 31848813
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
6. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces.
Lv Y; Li S; Liu Z; Ren Z; Zhao J; Tao G; Zheng Z; Han Y; Ye B
Lung Cancer; 2023 Mar; 177():51-58. PubMed ID: 36736075
[TBL] [Abstract][Full Text] [Related]
7. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma.
Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Mimura T; Murakami S; Ito H; Miyata Y; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2016 Jan; 49(1):293-9. PubMed ID: 25762400
[TBL] [Abstract][Full Text] [Related]
8. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
[TBL] [Abstract][Full Text] [Related]
10. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
[TBL] [Abstract][Full Text] [Related]
11. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
[TBL] [Abstract][Full Text] [Related]
12. Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study.
Chen D; Wang X; Zhang F; Han R; Ding Q; Xu X; Shu J; Ye F; Shi L; Mao Y; Chen Y; Chen C
Ther Adv Med Oncol; 2020; 12():1758835920978147. PubMed ID: 33403018
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components.
Li Y; Zhao J; Zhao Y; Li R; Dong X; Yao X; Xia Z; Xu Y; Li Y
Cancer Med; 2024 Feb; 13(3):e7030. PubMed ID: 38400663
[TBL] [Abstract][Full Text] [Related]
14. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
Wang Y; Song W; Wang X; Che G
Pathol Res Pract; 2023 Feb; 242():154314. PubMed ID: 36706587
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
17. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
Lv C; An C; Feng Q; Ma Y; Li S; Wang J; Zhang J; Wang X; Yan S; Fang J; Wang Y; Tan F; Yang Y
Clin Lung Cancer; 2015 Nov; 16(6):e173-81. PubMed ID: 25958850
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma.
Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
Oncology; 2024; 102(4):366-373. PubMed ID: 37899040
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of micropapillary pattern in pulmonary adenocarcinoma].
Lin DM; Ma Y; Liu XY; Zheng S; Xue LY; Liu XY; Zou SM; Lü N; He ZG; Liu FS
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):151-4. PubMed ID: 16630503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]